Evaluation of Several Tumor Markers (MCA, CA 15.3, BCM and CA 549) in Tissue and Serum of Patients with Breast Cancer
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- MCA in Patients with Breast Cancer: Correlation with CEA and CA15-3The International Journal of Biological Markers, 1990
- A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancerCancer, 1989
- A new biomarker in monitoring breast cancer: CA 549.Journal of Clinical Oncology, 1988
- The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissuesVirchows Archiv, 1988
- CA‐549: A new tumor marker for patients with advanced breast cancerJournal of Clinical Laboratory Analysis, 1988
- Comparison of circulating mam‐6 and cea levels and correlation with the estrogen receptor in patients with breast cancerInternational Journal of Cancer, 1987
- Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.Journal of Clinical Oncology, 1986
- Monoclonal antibodies against antigens on breast cancer cellsCellular and Molecular Life Sciences, 1985
- Monoclonal antibodies against human milk‐fat globule membranes detecting differentiation antigens of the mammary gland and its tumorsInternational Journal of Cancer, 1984
- Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast TumorsHybridoma, 1984